Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Adjuvant Dapagliflozin on Improving the Treatment of Congestion in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF)

NCT05406505 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05406505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Adjuvant Dapagliflozin on Improving the Treatment of Congestion in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF)
Lead sponsor
Mansoura University
Phase
Phase 2/3
Overall status
Completed
Start date
April 25, 2022
Completion date
July 1, 2023
Enrollment
87 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure